Dr Stephan Schürer from the University of Miami speaks about the goals of the BioAssay Ontology Project to enable standardized description, integration and meta-analysis of assay and screening results - http://bit.ly/15HpwvN
Dr Schürer will be discussing this topic in more detail at ELA 2013 as part of the Drug Discovery Automation track - http://bit.ly/16jbuPq
In this week's blog entry - http://bit.ly/15HpwvN - Dr Quail gives us some insight into the current advances being made in NGS, as well as some of the challenges still facing the optimisation of NGS pipelines.
Dr Quail will be speaking at ELA 2013 about the new NGS applications being developed at the Sanger Institute, as well as some of improvements his team are making to sequencing protocols.
This week’s ELA blog - http://bit.ly/15HpwvN -discusses the impact of process optimisation on cell based assays, with particular reference to High Content Analysis (HCA). To give us the inside scoop, we chatted with Dr Anthony Davies, Director of the High Content Research Facility at the Irish National Center for High Content Screening and Analysis (INCHSA) at Trinity College, Dublin, about the impact automation has had on the workflow at INCHSA. Dr Davies will also be sharing his expertise at E
Dr Holger Becker, Chief Scientific Officer of microfluidic ChipShop GmbH, discusses the great potential of microfluidics in our latest blog entry – http://bit.ly/15HpwvN.
Dr Becker will also be running a training course on ‘Microfluidics from the Concept to a Product: Technologies, Applications and Commercialisation Strategies’ at ELA on June 5th http://bit.ly/13ovJPE
In the run up to European Lab Automation 2013, we’ll be sharing some interesting news and insights around the event on our new blog - http://tinyurl.com/aafeu9f .
We’d be delighted if you’d like to comment on some of our blog posts, adding your own thoughts and generally become a valued part of the conversation!
Keynote talk to be delivered by Dr Hakim Djaballah, Director, Memorial Sloan Kettering Cancer Center 'Illuminating Cellular Pathways through Combining High Content Assays with the BDA Method: Too Much Hay and Very Few Needles in Random RNAi Screening Stacks' at the DDA: High-content Screening & Cell Based Assays conference track at ELA. For the full agenda, please view: http://bit.ly/YSUu0P